Bristol-Myers Squibb buy tamam
Start price
03.01.19
/
50%
€43.41
Target price
04.11.21
€72.00
Performance (%)
17.75%
End price
05.11.21
€51.12
Summary
This prediction ended on 05.11.21 with a price of €51.12. The prediction had a final performance of 17.75%. A total of €4.86 was paid as dividends for this prediction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 12.834% | 12.834% | -4.814% | -23.804% |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% | 57.692% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% | 83.804% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% | 56.282% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% | 57.791% |
Comments by tamam for this prediction
In the thread Bristol-Myers Squibb diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 03.01.2019 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 59.93$ zu.
Kursziel geändert auf 62,0
Kursziel geändert auf 72,0
In the thread Trading Bristol-Myers Squibb
Die von tamam gewählte maximale Laufzeit wurde überschritten